{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:03Z","timestamp":1786998423866,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8207051525"],"award-info":[{"award-number":["8207051525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.yebeh.2023.109364","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T02:53:05Z","timestamp":1690599185000},"page":"109364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Drug-resistant idiopathic generalized epilepsy: A meta-analysis of prevalence and risk factors"],"prefix":"10.1016","volume":"146","author":[{"given":"Tong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2023.109364_b0005","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/epi.17236","article-title":"ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Hirsch","year":"2022","journal-title":"Epilepsia"},{"issue":"Suppl 9","key":"10.1016\/j.yebeh.2023.109364_b0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2005.00309.x","article-title":"Epidemiology of idiopathic generalized epilepsies","volume":"46","author":"Jallon","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1528-1157.1978.tb04500.x","article-title":"Incidence of epilepsy in children: a follow-up study three years after the first seizure","volume":"19","author":"Blom","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1528-1157.1980.tb04044.x","article-title":"Epidemiology of different types of epilepsy in school age children of Modena","volume":"21","author":"Cavazzuti","year":"1980","journal-title":"Italy Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1157.1983.tb04893.x","article-title":"Natural history of epileptic seizures","volume":"24","author":"Juul-Jensen","year":"1983","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0030","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/epi.12972","article-title":"Prevalence and etiology of epilepsy in a Norwegian county \u2013 a population based study","volume":"56","author":"Syvertsen","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/epi.13613","article-title":"Prevalence of juvenile myoclonic epilepsy in people <30 years of age \u2013 a population-based study in Norway","volume":"58","author":"Syvertsen","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0040","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1111\/epi.17410","article-title":"Drug resistance in idiopathic generalized epilepsies: evidence and concepts","volume":"63","author":"Gesche","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0050","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1528-1167.2012.03723.x","article-title":"The prognosis of idiopathic generalized epilepsy","volume":"53","author":"Seneviratne","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ene.13811","article-title":"Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors","volume":"26","author":"Stevelink","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2023.109364_b0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2023.109364_b0065","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.yebeh.2023.109364_b0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2023.109364_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2023.109364_b0080","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1111\/epi.13702","article-title":"Resistance to valproic acid as predictor of treatment resistance in genetic generalized epilepsies","volume":"58","author":"Gesche","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0085","doi-asserted-by":"crossref","first-page":"e2519","DOI":"10.1212\/WNL.0000000000010644","article-title":"Patterns and prognostic markers for treatment response in generalized epilepsies","volume":"95","author":"Gesche","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109364_b0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eplepsyres.2017.01.011","article-title":"Prognostic factors in patients with refractory idiopathic generalized epilepsy","volume":"130","author":"Gomez-Iba\u00f1ez","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2023.109364_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-0404.2001.00003.x","article-title":"Premature death in juvenile myoclonic epilepsy","volume":"104","author":"Genton","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2023.109364_b0100","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.yebeh.2015.09.027","article-title":"Predicting drug resistance in adult patients with generalized epilepsy: a case-control study","volume":"53","author":"Voll","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109364_b0105","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/brain\/awaa072","article-title":"Clinical and experimental insight into pathophysiology, comorbidity and therapy of absence seizures","volume":"143","author":"Crunelli","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2023.109364_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.844674","article-title":"Generalized fast discharges along the genetic generalized epilepsy spectrum: clinical and prognostic significance","volume":"13","author":"Cerulli Irelli","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2023.109364_b0115","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1528-1167.2009.02198.x","article-title":"Frontal and temporal volumes in Childhood Absence Epilepsy","volume":"50","author":"Caplan","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0120","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1212\/WNL.0b013e3182a9f3ca","article-title":"Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy","volume":"81","author":"Masur","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109364_b0125","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa0902014","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy","volume":"362","author":"Glauser","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2023.109364_b0130","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/0883073815623632","article-title":"Evaluation of executive functions in patients with childhood absence epilepsy","volume":"31","author":"Gencpinar","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2023.109364_b0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.braindev.2017.09.006","article-title":"Attention profiles in childhood absence epilepsy compared with attention-deficit\/hyperactivity disorder","volume":"40","author":"Lee","year":"2018","journal-title":"Brain Develop"},{"key":"10.1016\/j.yebeh.2023.109364_b0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022756","article-title":"Single-gene determinants of epilepsy comorbidity","volume":"5","author":"Noebels","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yebeh.2023.109364_b0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/epi.12028","article-title":"Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1535-7597.2002.00024.x","article-title":"Block of thalamic T-type Ca(2+) channels by ethosuximide is not the whole story","volume":"2","author":"Crunelli","year":"2002","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2023.109364_b0155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0079-6123(05)50020-7","article-title":"Consciousness and epilepsy: why are patients with absence seizures absent?","volume":"150","author":"Blumenfeld","year":"2005","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.yebeh.2023.109364_b0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S1092852918001062","article-title":"Neuronal underpinnings of cognitive impairment and \u2013 improvement in mood disorders","volume":"24","author":"Miskowiak","year":"2019","journal-title":"CNS Spectr"},{"key":"10.1016\/j.yebeh.2023.109364_b0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbr.2019.04.002","article-title":"The neural systems of emotion regulation and abnormalities in major depressive disorder","volume":"367","author":"Park","year":"2019","journal-title":"Behav Brain Res"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2023.109364_b0170","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.yebeh.2012.06.035","article-title":"Juvenile myoclonic epilepsy\u2013neuroimaging findings","volume":"28","author":"Koepp","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2023.109364_b0175","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/brain\/awr098","article-title":"Motor system hyperconnectivity in juvenile myoclonic epilepsy: a cognitive functional magnetic resonance imaging study","volume":"134","author":"Vollmar","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2023.109364_b0180","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/brain.2021.0035","article-title":"Altered structural brain networks in refractory and nonrefractory idiopathic generalized epilepsy","volume":"12","author":"McKavanagh","year":"2022","journal-title":"Brain Connect"},{"key":"10.1016\/j.yebeh.2023.109364_b0185","article-title":"Atrophy in the left amygdala predicted drug responses in idiopathic generalized epilepsy patients with tonic-clonic seizures","volume":"15","author":"Li","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yebeh.2023.109364_b0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/epi.17104","article-title":"Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy","volume":"63","author":"Kamitaki","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109364_b0195","doi-asserted-by":"crossref","first-page":"e1822","DOI":"10.1212\/WNL.0000000000006472","article-title":"Generalized polyspike train: an EEG biomarker of drug-resistant idiopathic generalized epilepsy","volume":"91","author":"Sun","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109364_b0200","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ana.25554","article-title":"Subicular pyramidal neurons gate drug resistance in temporal lobe epilepsy","volume":"86","author":"Xu","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2023.109364_b0205","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1002\/hbm.25644","article-title":"Probabilistic mapping of thalamic nuclei and thalamocortical functional connectivity in idiopathic generalised epilepsy","volume":"42","author":"Chen","year":"2021","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.yebeh.2023.109364_b0210","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1093\/brain\/aws296","article-title":"Abnormal thalamocortical structural and functional connectivity in juvenile myoclonic epilepsy","volume":"135","author":"O'Muircheartaigh","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2023.109364_b0215","doi-asserted-by":"crossref","first-page":"e16402","DOI":"10.1097\/MD.0000000000016402","article-title":"Risk factors for drug-resistant epilepsy: a systematic review and meta-analysis","volume":"98","author":"Xue-Ping","year":"2019","journal-title":"Medicine (Baltimore)"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023002834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023002834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:50:20Z","timestamp":1761504620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023002834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":43,"alternative-id":["S1525505023002834"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109364","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-resistant idiopathic generalized epilepsy: A meta-analysis of prevalence and risk factors","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109364"}}